Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 20, 2018

Radium-223 Dichloride in Combination With VEGF-Targeting Therapy in Advanced RCC With Bone Metastases

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Radium-223 Dichloride in Combination With Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma With Bone Metastases
Clin. Cancer Res 2018 May 30;[EPub Ahead of Print], RR McKay, D Bossé, KP Gray, MD Michaelson, KM Krajewski, HA Jacene, M Meghara Walsh, J Bellmunt, M Pomerantz, LC Harshman, TK Choueiri

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.


Further Reading